Investigates Danggui Sini decoction's mechanisms in diabetic foot ulcer, suggesting multi-target potential.
Diabetic foot ulcer (DFU) is a severe diabetes complication characterized by chronic inflammation and impaired wound healing. This study aimed to investigated Danggui Sini decoction's (DSD) mechanisms through network pharmacology, molecular docking, and molecular dynamics simulations. We identified143 common targets, with AKT1, IL6, and TNF are core targets involved in inflammation, and angiogenesis. Key active compounds, including quercetin, naringenin, and kaempferol, showed strong AKT1 binding affinities (-9.1, -8.7, and -8.2 kcal/mol, respectively). MD simulations showed that the binding of quercetin and naringenin increased AKT1 C-terminal flexibility, potentially modulating downstream signaling. These findings reveal the potential multi-target mechanisms of DSD for DFU treatment.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: